Abstract
Mutations in Angiogenin (ANG) and TARDBP encoding the 43 kDa transactive response DNA binding protein (TDP-43) are associated with amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). ANG is neuroprotective and plays a role in stem cell dynamics in the haematopoietic system. We obtained skin fibroblasts from members of an ALS-FTD family, one with mutation in ANG, one with mutation in both TARDBP and ANG, and one with neither mutation. We reprogrammed these fibroblasts to induced pluripotent stem cells (iPSCs) and generated cortical organoids as well as induced stage-wise differentiation of the iPSCs to neurons. Using these two approaches we investigated the effects of FTD-associated mutations in ANG and TARDBP on neural precursor cells, neural differentiation, and response to stress. We observed striking neurodevelopmental defects such as abnormal and persistent rosettes in the organoids accompanied by increased self-renewal of neural precursor cells. There was also a propensity for differentiation to later-born neurons. In addition, cortical neurons showed increased susceptibility to stress, which is exacerbated in neurons carrying mutations in both ANG and TARDBP. The cortical organoids and neurons generated from patient-derived iPSCs carrying ANG and TARDBP gene variants recapitulate dysfunctions characteristic of frontotemporal lobar degeneration observed in FTD patients. These dysfunctions were ameliorated upon treatment with wild type ANG. In addition to its well-established role during the stress response of mature neurons, ANG also appears to play a role in neural progenitor dynamics. This has implications for neurogenesis and may indicate that subtle developmental defects play a role in disease susceptibility or onset.
Original language | English |
---|---|
Pages (from-to) | 410-426 |
Number of pages | 17 |
Journal | The Journal of Pathology |
Volume | 262 |
Issue number | 4 |
Early online date | 5 Jan 2024 |
DOIs | |
Publication status | Published - 30 Apr 2024 |
Data Availability Statement
All data generated or analysed during this study are included in this published article and its supplementary information files.Funding
We would like to thank Professor Peter W Andrews, University of Sheffield, for the kind gift of the antibodies SSEA3 and 4 as well as the Shef1 human ES cell line. The following antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the National Institutes of Health and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242: TROMA-I was developed by Brulet, P. and Kemler, R. (Institut Pasteur), 2H3 was developed by Jessell, T. M. and Dodd, J. (HHMI/Columbia University). We would like to thank Professor K Acharya, University of Bath, for the kind gift of recombinant ANG, Professor Guo-fu Hu, Tufts University, for the kind gift of the antibody 26-2F, and Dr Robert Shapiro for the kind gift of NCI 65828. The research was funded by project grants from NC3Rs (Grant G0900786), BRACE (REBB1285), and Wellcome Trust (084562/Z/07/Z) to VS. We would like to thank Professor Peter W Andrews, University of Sheffield, for the kind gift of the antibodies SSEA3 and 4 as well as the Shef1 human ES cell line. The following antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the National Institutes of Health and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242: TROMA‐I was developed by Brulet, P. and Kemler, R. (Institut Pasteur), 2H3 was developed by Jessell, T. M. and Dodd, J. (HHMI/Columbia University). We would like to thank Professor K Acharya, University of Bath, for the kind gift of recombinant ANG, Professor Guo‐fu Hu, Tufts University, for the kind gift of the antibody 26‐2F, and Dr Robert Shapiro for the kind gift of NCI 65828. The research was funded by project grants from NC3Rs (Grant G0900786), BRACE (REBB1285), and Wellcome Trust (084562/Z/07/Z) to VS.
Funders | Funder number |
---|---|
National Institutes of Health | |
Howard Hughes Medical Institute | |
National Cancer Institute | 65828 |
National Cancer Institute | |
Columbia University | |
Tufts University | |
Eunice Kennedy Shriver National Institute of Child Health and Human Development | |
The Wellcome Trust | 084562/Z/07/Z |
The Wellcome Trust | |
BRACE | REBB1285 |
BRACE | |
University of Sheffield | |
Institut Pasteur | |
National Centre for the Replacement Refinement and Reduction of Animals in Research | G0900786 |
National Centre for the Replacement Refinement and Reduction of Animals in Research |
Keywords
- Angiogenin
- cortical organoids
- induced pluripotent stem cells
- neural stem cells
- protein synthesis
ASJC Scopus subject areas
- Pathology and Forensic Medicine